Search Results
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by KeeMing Chia in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Heloisa Milioli in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Neil Portman in
Google Scholar
PubMed
Search for other papers by Geraldine Laven-Law in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Rhiannon Coulson in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Aliza Yong in
Google Scholar
PubMed
Search for other papers by Davendra Segara in
Google Scholar
PubMed
Search for other papers by Andrew Parker in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Catherine E Caldon in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Niantao Deng in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Alexander Swarbrick in
Google Scholar
PubMed
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Search for other papers by Theresa E Hickey in
Google Scholar
PubMed
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia
Search for other papers by Elgene Lim in
Google Scholar
PubMed
been implicated in the pathogenesis of other malignancies such as ovarian teratocarcinoma ( Chung et al . 2014 ) and some subtypes of breast cancer ( Hickey et al . 2012 , Chia et al . 2015 ). Breast cancer is a highly heterogeneous disease
Search for other papers by Vanessa W Lim in
Google Scholar
PubMed
Search for other papers by Jun Li in
Google Scholar
PubMed
Search for other papers by Yinhan Gong in
Google Scholar
PubMed
Search for other papers by Aizhen Jin in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, National Registry of Diseases Office, Division of Cancer Control and Population Sciences, Department of Epidemiology, Duke-NUS Graduate Medical School Singapore, Saw Swee Hock School of Public Health, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, NUHS Tower Block, Level 12, 1E Kent Ridge Road, Singapore 119228, Singapore
Search for other papers by Jian-Min Yuan in
Google Scholar
PubMed
Search for other papers by Eu Leong Yong in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, National Registry of Diseases Office, Division of Cancer Control and Population Sciences, Department of Epidemiology, Duke-NUS Graduate Medical School Singapore, Saw Swee Hock School of Public Health, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, NUHS Tower Block, Level 12, 1E Kent Ridge Road, Singapore 119228, Singapore
Search for other papers by Woon-Puay Koh in
Google Scholar
PubMed
Introduction There is ample experimental, epidemiological, and clinical evidence linking estrogens and breast cancer risk ( Henderson & Feigelson 2000 , Russo & Russo 2006 ). Several established risk factors for breast cancer are strongly
Search for other papers by N Angelopoulos in
Google Scholar
PubMed
Search for other papers by V Barbounis in
Google Scholar
PubMed
Search for other papers by S Livadas in
Google Scholar
PubMed
Search for other papers by D Kaltsas in
Google Scholar
PubMed
Search for other papers by G Tolis in
Google Scholar
PubMed
Introduction Adjuvant therapy in breast cancer consists of hormonal therapy with or without chemotherapy given after surgical excision of the tumor. The goal of hormonal adjuvant treatment in early breast cancer is the inhibition
Search for other papers by Eva Baxter in
Google Scholar
PubMed
Search for other papers by Karolina Windloch in
Google Scholar
PubMed
Search for other papers by Greg Kelly in
Google Scholar
PubMed
Search for other papers by Jason S Lee in
Google Scholar
PubMed
Search for other papers by Frank Gannon in
Google Scholar
PubMed
Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland
Search for other papers by Donal J Brennan in
Google Scholar
PubMed
Introduction Over 1000 oestrogen-responsive genes have been identified in vitro , predominantly using the luminal breast cancer cell line MCF7, and these are involved in a variety of processes such as the cell cycle, proliferation and
Search for other papers by P Kauraniemi in
Google Scholar
PubMed
Search for other papers by A Kallioniemi in
Google Scholar
PubMed
Introduction The ERBB2 ( neu / HER2 ) oncogene, located at chromosome 17q12, is one of the most intensively studied genes in cancer, especially in breast cancer. ERBB2 encodes for a 185 kDa transmembrane glycoprotein that belongs
Search for other papers by Dennis H Dowhan in
Google Scholar
PubMed
Search for other papers by Matthew J Harrison in
Google Scholar
PubMed
Search for other papers by Natalie A Eriksson in
Google Scholar
PubMed
Search for other papers by Peter Bailey in
Google Scholar
PubMed
Search for other papers by Michael A Pearen in
Google Scholar
PubMed
Search for other papers by Peter J Fuller in
Google Scholar
PubMed
Search for other papers by John W Funder in
Google Scholar
PubMed
Search for other papers by Evan R Simpson in
Google Scholar
PubMed
Search for other papers by Peter J Leedman in
Google Scholar
PubMed
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Search for other papers by Melissa A Brown in
Google Scholar
PubMed
Search for other papers by Christine L Clarke in
Google Scholar
PubMed
Search for other papers by George E O Muscat in
Google Scholar
PubMed
vascular endothelial growth factor ( VEGF ( VEGFA )) and spleen tyrosine kinase ( SYK ) genes in MCF-7 and T-47D breast cancer cells ( Harrison et al . 2010 ). Initial studies have identified several PRMT proteins as having a key role in SHR
Search for other papers by T Nagahata in
Google Scholar
PubMed
Search for other papers by T Sato in
Google Scholar
PubMed
Search for other papers by A Tomura in
Google Scholar
PubMed
Search for other papers by M Onda in
Google Scholar
PubMed
Search for other papers by K Nishikawa in
Google Scholar
PubMed
Search for other papers by M Emi in
Google Scholar
PubMed
Introduction One million women worldwide are diagnosed with breast cancer every year. Estrogen receptor (ER)-positive breast cancers generally have a better prognosis because adjuvant hormonal therapy with anti-estrogen reagents such
Search for other papers by P L Jeffery in
Google Scholar
PubMed
Search for other papers by R E Murray in
Google Scholar
PubMed
Search for other papers by A H Yeh in
Google Scholar
PubMed
Search for other papers by J F McNamara in
Google Scholar
PubMed
Search for other papers by R P Duncan in
Google Scholar
PubMed
Search for other papers by G D Francis in
Google Scholar
PubMed
Search for other papers by A C Herington in
Google Scholar
PubMed
Search for other papers by L K Chopin in
Google Scholar
PubMed
Introduction Breast cancer is the most commonly diagnosed malignancy in Western women ( Jemal et al. 2004 ) and is a significant cause of mortality and morbidity. Ovarian hormones and their receptors are essential for normal
The Dr Pinchas Borenstein Talpiot Medical Leadership Program 2013, Tel-Hashomer, Israel
Search for other papers by Gadi Shlomai in
Google Scholar
PubMed
Search for other papers by Zara Zelenko in
Google Scholar
PubMed
Search for other papers by Irini Markella Antoniou in
Google Scholar
PubMed
Search for other papers by Marilyn Stasinopoulos in
Google Scholar
PubMed
Search for other papers by Aviva Tobin-Hess in
Google Scholar
PubMed
Department of Neurology, Duke University Medical Center, Research Drive, Durham, North Carolina, USA
Search for other papers by Michael P Vitek in
Google Scholar
PubMed
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
Search for other papers by Emily Jane Gallagher in
Google Scholar
PubMed
breast cancer incidence, metastases and recurrence ( Calle et al . 2003 , Stattin et al . 2007 , Giovannucci et al . 2010 , Campbell et al . 2012 , Tancredi et al . 2015 , Handelsman et al . 2016 ). Approximately 70% of obese women and almost
Search for other papers by Marc Lacroix in
Google Scholar
PubMed
Introduction Despite the improvements in detection and the treatment of breast cancer, about 40% of patients still succumb to the disease. The development of distant metastases is the major cause of these deaths. Breast cancer is